FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

KA Benton

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Concepts & Ideas

Phenomena

Species Specificity

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Calvin C Daniels; Patricia Coan; Janice King; Joanetha Hale; KA Benton; David E Briles; Susan Kay Hollingshead
The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.
David E Briles; R C Tart; Edwin Swiatlo; J P Dillard; P Smith; KA Benton; B A Ralph; Alexis Brooks-Walter; Marilyn J Crain; Susan Kay Hollingshead; Larry McDaniel
Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).
KA Benton; John L VanCott; David E Briles
Role of tumor necrosis factor alpha in the host response of mice to bacteremia caused by pneumolysin-deficient Streptococcus pneumoniae.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of KA Benton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Calvin C Daniels; Patricia Coan; Janice King; Joanetha Hale; KA Benton; David E Briles; Susan Kay Hollingshead
The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.
Infection and immunity 2010;78(5):2163-72.
1998: David E Briles; R C Tart; Edwin Swiatlo; J P Dillard; P Smith; KA Benton; B A Ralph; Alexis Brooks-Walter; Marilyn J Crain; Susan Kay Hollingshead; Larry McDaniel
Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).
Clinical microbiology reviews 1998;11(4):645-57.
1998: KA Benton; John L VanCott; David E Briles
Role of tumor necrosis factor alpha in the host response of mice to bacteremia caused by pneumolysin-deficient Streptococcus pneumoniae.
Infection and immunity 1998;66(2):839-42.
1997: KA Benton; James C Paton; David E Briles
The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model.
Microbial pathogenesis 1997;23(4):201-9.
1997: KA Benton; James C Paton; David E Briles
Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production.
Infection and immunity 1997;65(4):1237-44.
1997: David E Briles; Susan Kay Hollingshead; Edwin Swiatlo; Alexis Brooks-Walter; Alexander Szalai; A Virolainen; Larry McDaniel; KA Benton; P White; Karin Prellner; A Hermansson; P C Aerts; H Van Dijk; Marilyn J Crain
PspA and PspC: their potential for use as pneumococcal vaccines.
Microbial drug resistance (Larchmont, N.Y.) 1997;3(4):401-8.
1996: David E Briles; J D King; M A Gray; Larry McDaniel; Edwin Swiatlo; KA Benton
PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice.
Vaccine 1996;14(9):858-67.
1996: E Swiatlo; KA Benton; David E Briles
Pneumococcal vaccine response in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 1996;173(3):777-8.
1995: KA Benton; MP Everson; David E Briles
A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice.
Infection and immunity 1995;63(2):448-55.